Divi's Laboratories Ltd

• Country

  India

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Life Sciences Tools & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  12042.1

• Ticker

  DIVI.NS

• ISIN

  INE361B01024

• IPO date

  1905-06-25

• Availability on Russian exchanges

  No

• Reporting for

  2024-02-10

• Date fact. publication of reports

  2023-12-31

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Betacarotene, Lycopene, Astaxanthin and Canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in the State of Andhra Pradesh and Telangana in India.